ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW
632.00
-32.00 (-4.82%)
Feb 26, 2026, 11:20 AM KST
Revenue by Segment
Financials in millions KRW. Fiscal year is April - March.
Millions KRW. Fiscal year is Apr - Mar.
| FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | Mar '18 Mar 31, 2018 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | Mar '15 Mar 31, 2015 | Mar '14 Mar 31, 2014 | Mar '13 Mar 31, 2013 | Mar '12 Mar 31, 2012 |
|---|
| - | - | 26.72B | 25.66B | 19.18B | | | | | |
Domestic Workplace Growth | - | - | 4.13% | 33.77% | -4.44% | | | | | |
| - | - | 8.01B | 12.62B | 20.87B | | | | | |
Overseas Business Sites Growth | - | - | -36.52% | -39.54% | 103.86% | | | | | |
Consolidation Mediation Journal | - | - | -4.36B | -5.64B | -10.52B | | | | | |
Laboratory Animal Manufacturing Division | 52.02B | 37.21B | - | - | - | | | | | |
Laboratory Animal Manufacturing Division Growth | 39.79% | - | - | - | - | | | | | |
| - | - | - | 61.08B | 54.05B | | | | | |
| - | - | - | 13.00% | -0.28% | | | | | |
| - | - | - | 27.49B | 25.43B | | | | | |
Power Supply Equipment Growth | - | - | - | 8.09% | 6.08% | | | | | |
| 52.02B | 37.21B | 30.37B | 121.21B | 109.02B | | | | | |
| 39.79% | 22.52% | -74.94% | 11.18% | 3.78% | | | | | |
Source: S&P Global Market Intelligence.